We've found
4,882
archived clinical trials in
Obesity Weight Loss
We've found
4,882
archived clinical trials in
Obesity Weight Loss
Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects
Updated: 8/21/2014
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects.
Status: Enrolling
Updated: 8/21/2014
Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects
Updated: 8/21/2014
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects.
Status: Enrolling
Updated: 8/21/2014
Click here to add this to my saved trials
Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
Updated: 8/27/2014
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P11187
Status: Enrolling
Updated: 8/27/2014
Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
Updated: 8/27/2014
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P11187
Status: Enrolling
Updated: 8/27/2014
Click here to add this to my saved trials
The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism
Updated: 9/19/2014
Pilot Study to Study the Effects of the Food Preservative Calcium Propionate on Postprandial Hormonal and Metabolic Milieu
Status: Enrolling
Updated: 9/19/2014
The Effects of the Food Preservative Propionic Acid in Post-prandial Metabolism
Updated: 9/19/2014
Pilot Study to Study the Effects of the Food Preservative Calcium Propionate on Postprandial Hormonal and Metabolic Milieu
Status: Enrolling
Updated: 9/19/2014
Click here to add this to my saved trials
LEVEL UP: Video Games for Activity in Breast Cancer Survivors
Updated: 9/29/2014
LEVEL UP: Leveraging Electronic Videogames for Exercise and Leisure: Understanding Preferences of Breast Cancer Survivors
Status: Enrolling
Updated: 9/29/2014
LEVEL UP: Video Games for Activity in Breast Cancer Survivors
Updated: 9/29/2014
LEVEL UP: Leveraging Electronic Videogames for Exercise and Leisure: Understanding Preferences of Breast Cancer Survivors
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Primary Care Beverage Study
Updated: 10/3/2014
Evaluation of a Primary Care-Based Intervention to Reduce Consumption of Sugar-sweetened Beverages and 100% Fruit Juice Among Latino Children
Status: Enrolling
Updated: 10/3/2014
Primary Care Beverage Study
Updated: 10/3/2014
Evaluation of a Primary Care-Based Intervention to Reduce Consumption of Sugar-sweetened Beverages and 100% Fruit Juice Among Latino Children
Status: Enrolling
Updated: 10/3/2014
Click here to add this to my saved trials
TT-CMV Observational Birth Cohort Study
Updated: 12/9/2014
Prevention of Transfusion-transmitted CMV (TT-CMV) in Lowbirth Weight Infants (LBWI; ≤1500 Grams) Using CMV Seronegative and Leukoreduced Transfusions.
Status: Enrolling
Updated: 12/9/2014
TT-CMV Observational Birth Cohort Study
Updated: 12/9/2014
Prevention of Transfusion-transmitted CMV (TT-CMV) in Lowbirth Weight Infants (LBWI; ≤1500 Grams) Using CMV Seronegative and Leukoreduced Transfusions.
Status: Enrolling
Updated: 12/9/2014
Click here to add this to my saved trials
TT-CMV Observational Birth Cohort Study
Updated: 12/9/2014
Prevention of Transfusion-transmitted CMV (TT-CMV) in Lowbirth Weight Infants (LBWI; ≤1500 Grams) Using CMV Seronegative and Leukoreduced Transfusions.
Status: Enrolling
Updated: 12/9/2014
TT-CMV Observational Birth Cohort Study
Updated: 12/9/2014
Prevention of Transfusion-transmitted CMV (TT-CMV) in Lowbirth Weight Infants (LBWI; ≤1500 Grams) Using CMV Seronegative and Leukoreduced Transfusions.
Status: Enrolling
Updated: 12/9/2014
Click here to add this to my saved trials
TT-CMV Observational Birth Cohort Study
Updated: 12/9/2014
Prevention of Transfusion-transmitted CMV (TT-CMV) in Lowbirth Weight Infants (LBWI; ≤1500 Grams) Using CMV Seronegative and Leukoreduced Transfusions.
Status: Enrolling
Updated: 12/9/2014
TT-CMV Observational Birth Cohort Study
Updated: 12/9/2014
Prevention of Transfusion-transmitted CMV (TT-CMV) in Lowbirth Weight Infants (LBWI; ≤1500 Grams) Using CMV Seronegative and Leukoreduced Transfusions.
Status: Enrolling
Updated: 12/9/2014
Click here to add this to my saved trials
Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)
Updated: 12/10/2014
Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)
Status: Enrolling
Updated: 12/10/2014
Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)
Updated: 12/10/2014
Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)
Status: Enrolling
Updated: 12/10/2014
Click here to add this to my saved trials
Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients
Status: Enrolling
Updated: 12/17/2014
Updated: 12/17/2014
Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients
Status: Enrolling
Updated: 12/17/2014
Updated: 12/17/2014
Click here to add this to my saved trials
Lean Body Mass Response to Higher-protein Diets During Winter Military Training
Updated: 12/22/2014
Effects of Carbohydrate and Protein Supplementation on Whole-body Protein Balance and Skeletal Muscle Mass During Winter Military Training: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/22/2014
Lean Body Mass Response to Higher-protein Diets During Winter Military Training
Updated: 12/22/2014
Effects of Carbohydrate and Protein Supplementation on Whole-body Protein Balance and Skeletal Muscle Mass During Winter Military Training: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/22/2014
Click here to add this to my saved trials
Metabolically Normal and Metabolically Abnormal Obesity
Updated: 12/30/2014
Metabolically Normal and Metabolically Abnormal Obesity
Status: Enrolling
Updated: 12/30/2014
Metabolically Normal and Metabolically Abnormal Obesity
Updated: 12/30/2014
Metabolically Normal and Metabolically Abnormal Obesity
Status: Enrolling
Updated: 12/30/2014
Click here to add this to my saved trials
Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
Updated: 1/5/2015
The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
Status: Enrolling
Updated: 1/5/2015
Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
Updated: 1/5/2015
The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
Status: Enrolling
Updated: 1/5/2015
Click here to add this to my saved trials
Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
Updated: 1/5/2015
The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
Status: Enrolling
Updated: 1/5/2015
Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
Updated: 1/5/2015
The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
Status: Enrolling
Updated: 1/5/2015
Click here to add this to my saved trials
MoTHER Buddy Program
Updated: 1/9/2015
With Help From Buddies: The Impact of Social Support Using Mobile Technology on Physical Activity Among Women With Young Children
Status: Enrolling
Updated: 1/9/2015
MoTHER Buddy Program
Updated: 1/9/2015
With Help From Buddies: The Impact of Social Support Using Mobile Technology on Physical Activity Among Women With Young Children
Status: Enrolling
Updated: 1/9/2015
Click here to add this to my saved trials
Creating Exercise Habits Through Incentives for Routines
Updated: 1/20/2015
Creating Exercise Habits Through Incentives for Routines
Status: Enrolling
Updated: 1/20/2015
Creating Exercise Habits Through Incentives for Routines
Updated: 1/20/2015
Creating Exercise Habits Through Incentives for Routines
Status: Enrolling
Updated: 1/20/2015
Click here to add this to my saved trials
Quincy Family, Youth & Technology For Lifestyle Change (FYT-4-LIFE) Study
Updated: 3/13/2015
Quincy Family, Youth & Technology For Lifestyle Change (FYT-4-LIFE) Study
Status: Enrolling
Updated: 3/13/2015
Quincy Family, Youth & Technology For Lifestyle Change (FYT-4-LIFE) Study
Updated: 3/13/2015
Quincy Family, Youth & Technology For Lifestyle Change (FYT-4-LIFE) Study
Status: Enrolling
Updated: 3/13/2015
Click here to add this to my saved trials
A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes
Updated: 3/19/2015
A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes
Status: Enrolling
Updated: 3/19/2015
A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes
Updated: 3/19/2015
A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 Diabetes
Status: Enrolling
Updated: 3/19/2015
Click here to add this to my saved trials
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Click here to add this to my saved trials
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Click here to add this to my saved trials
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Click here to add this to my saved trials
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Physical Activity Referrals to the Community
Updated: 4/9/2015
Primary Care Physical Activity Referrals to the Community
Status: Enrolling
Updated: 4/9/2015
Click here to add this to my saved trials
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
Updated: 4/14/2015
A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor
Status: Enrolling
Updated: 4/14/2015
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
Updated: 4/14/2015
A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor
Status: Enrolling
Updated: 4/14/2015
Click here to add this to my saved trials
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
Updated: 4/14/2015
A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor
Status: Enrolling
Updated: 4/14/2015
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
Updated: 4/14/2015
A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor
Status: Enrolling
Updated: 4/14/2015
Click here to add this to my saved trials
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
Updated: 4/14/2015
A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor
Status: Enrolling
Updated: 4/14/2015
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
Updated: 4/14/2015
A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor
Status: Enrolling
Updated: 4/14/2015
Click here to add this to my saved trials
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Updated: 5/5/2015
Obesity & Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status: Enrolling
Updated: 5/5/2015
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Updated: 5/5/2015
Obesity & Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status: Enrolling
Updated: 5/5/2015
Click here to add this to my saved trials
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Updated: 5/5/2015
Obesity & Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status: Enrolling
Updated: 5/5/2015
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Updated: 5/5/2015
Obesity & Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status: Enrolling
Updated: 5/5/2015
Click here to add this to my saved trials
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Updated: 5/5/2015
Obesity & Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status: Enrolling
Updated: 5/5/2015
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Updated: 5/5/2015
Obesity & Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
Status: Enrolling
Updated: 5/5/2015
Click here to add this to my saved trials
Armodafinil in Binge Eating Disorder (BED)
Status: Enrolling
Updated: 5/13/2015
Updated: 5/13/2015
Armodafinil in Binge Eating Disorder (BED)
Status: Enrolling
Updated: 5/13/2015
Updated: 5/13/2015
Click here to add this to my saved trials
Low-Dose Leptin and the Formerly-Obese
Updated: 6/3/2015
Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese
Status: Enrolling
Updated: 6/3/2015
Low-Dose Leptin and the Formerly-Obese
Updated: 6/3/2015
Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese
Status: Enrolling
Updated: 6/3/2015
Click here to add this to my saved trials
Self-Efficacy in Weight Loss Treatment
Updated: 7/2/2015
Self-Efficacy in Weight Loss Treatment
Status: Enrolling
Updated: 7/2/2015
Self-Efficacy in Weight Loss Treatment
Updated: 7/2/2015
Self-Efficacy in Weight Loss Treatment
Status: Enrolling
Updated: 7/2/2015
Click here to add this to my saved trials
Improving Self-Monitoring in Weight Loss With Technology
Updated: 7/2/2015
Improving Self-Monitoring in Weight Loss With Technology
Status: Enrolling
Updated: 7/2/2015
Improving Self-Monitoring in Weight Loss With Technology
Updated: 7/2/2015
Improving Self-Monitoring in Weight Loss With Technology
Status: Enrolling
Updated: 7/2/2015
Click here to add this to my saved trials
New Moves - Obesity Prevention Among Adolescent Girls
Updated: 7/6/2015
New Moves: Obesity Prevention Among Adolescent Girls
Status: Enrolling
Updated: 7/6/2015
New Moves - Obesity Prevention Among Adolescent Girls
Updated: 7/6/2015
New Moves: Obesity Prevention Among Adolescent Girls
Status: Enrolling
Updated: 7/6/2015
Click here to add this to my saved trials
Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens
Updated: 7/7/2015
Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens
Status: Enrolling
Updated: 7/7/2015
Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens
Updated: 7/7/2015
Mindfulness Training to Promote Healthy Diet and Physical Activity in Teens
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Effects of a Wholegrain Diet on Body Composition and Energy Balance
Updated: 7/8/2015
Effects of Diet on Body Composition
Status: Enrolling
Updated: 7/8/2015
Effects of a Wholegrain Diet on Body Composition and Energy Balance
Updated: 7/8/2015
Effects of Diet on Body Composition
Status: Enrolling
Updated: 7/8/2015
Click here to add this to my saved trials
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Updated: 7/9/2015
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Status: Enrolling
Updated: 7/9/2015
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Updated: 7/9/2015
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Status: Enrolling
Updated: 7/9/2015
Click here to add this to my saved trials
An Intergenerational Community Based Participatory Research (CBPR) Intervention to Reduce Appalachian Health Disparities
Updated: 7/10/2015
An Intergenerational CBPR Intervention to Reduce Appalachian Health Disparities
Status: Enrolling
Updated: 7/10/2015
An Intergenerational Community Based Participatory Research (CBPR) Intervention to Reduce Appalachian Health Disparities
Updated: 7/10/2015
An Intergenerational CBPR Intervention to Reduce Appalachian Health Disparities
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Creatine in Treating Patients With Cancer-Associated Weight Loss
Updated: 7/13/2015
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Status: Enrolling
Updated: 7/13/2015
Click here to add this to my saved trials